OKYO Pharma Ltd
OKYO3.120USD
+0.020+0.65%
收盘 08/04, 16:00（美东）报价延迟15分钟
3.120USD+3.120盘后交易 (美东)
112.38M总市值
--市盈率 TTM
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
FY2019H2
FY2019H1
营业费用
-61.77%3.34M
2.10%8.81M
91.74%8.73M
103.25%8.63M
131.15%4.56M
148.80%4.25M
127.57%1.97M
407.84%1.71M
-30.97%866.02K
-85.42%336.12K
6.80%1.25M
--2.31M
--1.17M
研发费用
-51.83%2.22M
6.31%4.46M
114.68%4.60M
231.95%4.20M
519.64%2.14M
1119.75%1.26M
1082.15%345.78K
-20.65%103.61K
-89.44%29.25K
-93.99%130.57K
69.98%276.91K
--2.17M
--162.91K
折旧摊销及损耗
-38.63%1.27K
-7.87%2.24K
51.53%2.08K
47.54%2.43K
-88.50%1.37K
-78.07%1.65K
373.01%11.91K
65.42%7.50K
1408.38%2.52K
2615.57%4.54K
--167.00
--167.00
----
其他营业费用
-72.83%1.12M
-1.89%4.35M
71.37%4.13M
48.73%4.44M
48.49%2.41M
86.05%2.98M
94.20%1.63M
680.03%1.60M
-14.42%836.77K
52.54%205.55K
-3.37%977.72K
--134.75K
--1.01M
营业利润
61.77%-3.34M
-2.10%-8.81M
-91.74%-8.73M
-103.25%-8.63M
-131.15%-4.56M
-148.80%-4.25M
-127.57%-1.97M
-407.84%-1.71M
30.97%-866.02K
85.42%-336.12K
-6.80%-1.25M
---2.31M
---1.17M
净非营业利息收入（费用）
利息收入
----
----
----
----
----
--736.00
----
----
--0.00
--37.85K
--0.00
--0.00
----
利息费用
--758.38K
989.40%1.05M
----
--96.69K
-100.00%0.00
----
87.76%736.00
-48.85%466.00
--392.00
--911.00
--0.00
--0.00
----
特殊收入（费用）
----
----
----
----
----
----
100.00%0.00
143.31%45.19K
18.31%-53.73K
62.51%-104.34K
---65.77K
---278.35K
----
其他非经营性收入（费用）
----
----
----
----
----
----
----
----
----
-99.88%21.00
----
--18.01K
---18.01K
税前利润
53.09%-4.10M
-13.03%-9.87M
-91.74%-8.73M
-105.57%-8.73M
-131.06%-4.56M
-155.45%-4.25M
-114.26%-1.97M
-311.95%-1.66M
30.31%-920.14K
84.27%-403.50K
-10.70%-1.32M
---2.57M
---1.19M
所得税
-1811.74%-1.42M
-255.43%-43.37K
--82.83K
98.12%-12.20K
100.00%0.00
-3292.75%-650.46K
-200192.65%-136.06K
68.05%-19.17K
--68.00
---60.00K
--0.00
--0.00
--0.00
除税后利润
69.61%-2.68M
-12.69%-9.82M
-93.56%-8.82M
-142.41%-8.72M
-148.19%-4.56M
-118.84%-3.60M
-99.46%-1.84M
-378.33%-1.64M
30.31%-920.21K
86.61%-343.50K
-10.70%-1.32M
---2.57M
---1.19M
持续经营利润
69.61%-2.68M
-12.69%-9.82M
-93.56%-8.82M
-142.41%-8.72M
-148.19%-4.56M
-118.84%-3.60M
-99.46%-1.84M
-378.33%-1.64M
30.31%-920.21K
86.61%-343.50K
-10.70%-1.32M
---2.57M
---1.19M
归属于母公司的净利润
69.61%-2.68M
-12.69%-9.82M
-93.56%-8.82M
-142.41%-8.72M
-148.19%-4.56M
-118.84%-3.60M
-99.46%-1.84M
-378.33%-1.64M
30.31%-920.21K
86.61%-343.50K
-10.70%-1.32M
---2.57M
---1.19M
归属于普通股东的净利润
69.61%-2.68M
-12.69%-9.82M
-93.56%-8.82M
-142.41%-8.72M
-148.19%-4.56M
-118.84%-3.60M
-99.46%-1.84M
-378.33%-1.64M
30.31%-920.21K
86.61%-343.50K
-10.70%-1.32M
---2.57M
---1.19M
基本每股收益
76.72%-0.08
21.84%-0.30
-62.82%-0.34
-199.78%-0.38
-60.40%-0.21
18.17%-0.13
-44.29%-0.13
-342.59%-0.16
41.18%-0.09
89.39%-0.04
-4.39%-0.15
---0.33
---0.15
稀释每股收益
76.72%-0.08
21.84%-0.30
-62.82%-0.34
-199.78%-0.38
-60.40%-0.21
18.17%-0.13
-44.29%-0.13
-342.59%-0.16
41.18%-0.09
89.39%-0.04
-4.39%-0.15
---0.33
---0.15
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
货币单位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
审计意见
--
--
--
--
--
--
--
--
--
--
--
--
--
